![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 11
Zeitschriftenartikel
Kempf, J.; Knelles, K.; Hersbach, B. A.; Petrik, D.; Riedemann, T.; Bednarova, V.; Janjic, A.; Simon-Ebert, T.; Enard, W.; Smialowski, P.; Goetz, M. und Masserdotti, G.
(2021):
Heterogeneity of neurons reprogrammed from spinal cord astrocytes by the proneural factors Ascl1 and Neurogenin2.
In: Cell Reports, Bd. 36, Nr. 3, 109409
[PDF, 7MB]
Schreiweis, C.; Irinopoulou, T.; Vieth, B.; Laddada, L.; Oury, F.; Burguiere, E.; Enard, W. und Groszer, M.
(2019):
Mice carrying a humanized Foxp2 knock-in allele show region-specific shifts of striatal Foxp2 expression levels.
In: Cortex, Bd. 118: S. 212-222
Valtierra-Gutierrez, I. A.; Farre-Orteu, A.; Richter, M.; Greif, P. A.; Ziegenhain, C.; Jeremias, I.; Metzeler, K.; Spiekermann, K.; Enard, W. und Hellmann, I.
(2017):
Detection of Single-Nucleotide Variants in Acute Myeloid Leukemia (AML) from Bulk and Single-Cell RNA Sequencing.
In: Annals of Hematology, Bd. 96:
S57-S57
Oezdemir, E.; Ziegenhain, C.; Panzer-Grünmayer, R.; Enard, W. und Jeremias, I.
(2017):
A Preclinical PDX Model for Patients` Minimal Residual Disease in ALL.
In: Annals of Hematology, Bd. 96:
S74-S74
Weickert, M.-T.; Garz, A.-K.; Hecker, J.; Ziegenhain, C.; Grath, S.; Strunk, D.; Peschel, C.; Enard, W.; Oostendorp, R. A. J. und Goetze, K. S.
(2017):
Significantly Reduced CFU-F Frequency and Increased Adipogenic Differentiation of Mesenchymal Stem Cells (Msc) in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML).
In: Annals of Hematology, Bd. 96:
S52-S52
Bagnoli, Johannes; Ziegenhain, C.; Vieth, B.; Parekh, S.; Vick, B.; Jeremias, I.; Hellmann, I. und Enard, W.
(2017):
Transcriptional Heterogeneity in AML - Evolution of Gene Expression in Patient Derived Xenografts.
In: Annals of Hematology, Bd. 96:
S59-S59
Richter, D.; Bartels, A.; Metzeler, K. und Enard, W.
(2017):
Studying Clonal Dynamics in Cytogenetically Normal AML through Sensitive Backtracking of Relapse-Associated Mutations.
In: Annals of Hematology, Bd. 96:
S61-S61
Ziegenhain, C.; Vieth, B.; Parekh, S.; Reinius, B.; Guillaumet-Adkins, A.; Smets, M.; Leonhardt, H.; Heyn, H.; Hellmann, I. und Enard, W.
(2017):
Comparative Analysis of Single-Cell - RNA Sequencing Methods.
In: Annals of Hematology, Bd. 96:
S58-S58
Schreck, C.; Istvanffy, R.; Ziegenhain, C.; Sippenauer, T.; Prendergast, Á.; Mende, N.; Gärtner, F.; Massberg, S.; Essers, M.; Waskow, C.; Peschel, C.; Enard, W. und Oostendorp, R.
(2016):
WNT5A from the niche regulates the actin regulatory pathway in hematopoietic stem cells.
In: Haematologica, Bd. 101: S. 118
Weickert, M.-T.; Garz, A.-K.; Zwick, A.; Ziegenhain, C.; Grath, S.; Strunk, D.; Enard, W.; Peschel, C.; Oostendorp, R. und Götze, K. S.
(2016):
Frequency and clonogenic capacity of the rare CFU-F subpopulation of Mesenchymal Stem Cells (MSC) is significantly reduced in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML).
In: Oncology Research and Treatment, Bd. 39: S. 124-125
Oostendorp, R.; Schreck, C.; Ziegenhain, C.; Sippenauer, T.; Ruf, F.; Vilne, B.; Peschel, C.; Enard, W.; Götze, K. und Istvanffy, R.
(2016):
The niche protects hematopoietic stem cells through cytokines which regulate DNA repair and cytoskeleton dynamics.
In: Oncology Research and Treatment, Bd. 39: S. 251